Women Health Hospital - Assiut university
Asyut, 71111, Egypt
NCT Number: NCT03404986
The prevalence of urolithiasis is steadily increasing with an estimation of 1 out of 11 people in the United States. The prevalence of calculi in Afro-Asian region including Arab Republic of Egypt ranges from 4% to 20%. Ureteroscopy is one of the first line treatments for definitive management of ureteric stones. Conventional ureteroscopy relies on intraoperative fluoroscopy for visualization and guidance, exposing the patient, surgeon and operating room staff to ionizing radiation. To minimize the hazards of ionizing radiation there has been a trend toward radiation free alternative imaging modalities . Ultrasound provides an excellent alternative for upper urinary tract imaging because it is radiation free, rapid, portable and allows excellent visualization of the renal pelvis and calyces. There is increasing awareness and concern about the clinical use of ionizing radiation and the need to decrease exposure of patients and medical professionals. Ultrasound guided ureteroscopy in pregnant females and children- in whom fluoroscopy is to be minimized or avoided when possible - has been reported.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Asyut, 71111, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients will be subjected to rigid ureteroscopy
The patients will be subjected to Ultrasonography
Time frame: 1 hour
Assiut University
Other
Ultrasound Guided Ureteroscopy for the Treatment of Lower Third Ureteric Stones in Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06975488
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Sahiwal, Punjab Province, Pakistan
View Trial DetailsNCT06761378
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, State Or Province, Egypt
View Trial DetailsNCT04759417
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT06465784
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Damietta, Egypt
View Trial Details